Skip to search formSkip to main contentSkip to account menu

Papillomavirus Transforming Protein E7

Known as: E7, Viral Protein E7 
Complexes with and inactivates Rb protein resulting in disruption of cell cycle regulation.
National Institutes of Health

Related topics

Related topics

4 relations
Genes, ViralNeoplastic Cell TransformationOncogenesVirus

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Infusion of Ex Vivo Expanded Allogeneic Cord Blood-Derived Natural Killer Cells in Combination with Autologous Stem Cell Transplantation for Multiple Myeloma: Results of a Phase I Study
Background: Multiple myeloma (MM) is an incurable disease thought to be characterized by immune dysregulation and exhaustion… 
2013
2013
Abstract 4776: Expression of Human Papillomavirus E6 and E7 genes in colorectal cancer.
Purpose: The role of human papillomavirus (HPV) has been well established in the pathogenesis on cervical cancers and anogenital… 
2010
2010
E6 or e7 fusion immunoglobulin from human papillomavirus type 16
The present invention is a recombinant HPV 16 type E6 or E7 fusion relates to an immunoglobulin, more specifically, HPV 16 type… 
2006
2006
Assays for determining malignant transformation of cervical cells by expression of hpv e6, e7 mrna
Provided is an HPV E6, E7 mRNA assay, referenced herein as the "In Cell HPV Assay," that is capable of sensitive and specific… 
2006
2006
Deregulation of eIF 4 E : 4 EBP 1 in Differentiated Human Papillomavirus-Containing Cells Leads to High Levels of Expression of the E 7 Oncoprotein
Infections with high-risk human papillomaviruses (HPVs) are linked to more than 95% of cervical cancers. HPVs replicate… 
2003
2003
Non-immunosuppressive immunogenic or vaccine consisting of mutated e7 protein Hpv-16 virus
An immune vaccine composition elicits an immune response against HPV-16 papillomavirus (Papillomavirus) native E7 protein without… 
2002
2002
cd4 positive t cells activated with novel epitopes and epitope thereof of a human papillomavirus e7 antigen
The invention, its object to provide a human papilloma virus antigen on the epitopes and activated uterine cancer lesions and… 
2001
2001
Hpv e7 for treatment of human papillomavirus
1989
1989
Activation of integrated hpv16 e6 e7 genes by cellular flanking sequences
1985
1985
Mapping the genes in the terminal redundancy of bacteriophage SPO1 with restriction endonucleases
Although most early transcription from SPO1, a lytic DNA bacteriophage of Bacillus subtilis, is specified by the 12.6-kilobase…